大麻困境：对其相关风险和临床疗效的综述
The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy.
作者信息
Zhang Melvyn Weibin, Ho Roger C M
机构信息
National Addiction Management Service, Institute of Mental Health, Singapore 539747.
Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119054.
出版信息
J Addict. 2015;2015:707596. doi: 10.1155/2015/707596. Epub 2015 Oct 11.
Abstract
Cannabis, also known as marijuana, has 9-tetrahydrocannabinol as the main constituent. There has been strict legislation governing the utilization of cannabis locally and worldwide. However, there has been an increasing push to make cannabis legalized, in view of its potential medical and therapeutic effects, for various medical disorders ranging from development disorders to cancer treatment, and being an adjunctive medication for various neurological conditions. It is the aim of this review paper to explore the evidence base for its proposed therapeutic efficacy and to compare the evidence base supporting its proposed therapeutic efficacy with its known and well-researched medical and psychiatric side effects.
摘要
大麻，也被称为 marijuana，其主要成分是 9 - 四氢大麻酚。在本地和全球范围内，都有严格管理大麻使用的法律。然而，鉴于其对从发育障碍到癌症治疗等各种医学病症具有潜在的医学和治疗效果，并且作为各种神经病症的辅助药物，要求将大麻合法化的呼声越来越高。这篇综述论文的目的是探究其声称的治疗效果的证据基础，并将支持其声称的治疗效果的证据基础与其已知且经过充分研究的医学和精神方面的副作用进行比较。
相似文献
1
The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy.大麻困境：对其相关风险和临床疗效的综述
J Addict. 2015;2015:707596. doi: 10.1155/2015/707596. Epub 2015 Oct 11.
2
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….医用大麻、大麻素及其在医学和头痛治疗中的意义综述：这是一段多么漫长而奇特的旅程啊……
Headache. 2015 Jun;55(6):885-916. doi: 10.1111/head.12570. Epub 2015 May 25.
3
The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review.大麻使用与精神分裂症之间的关联：因果关系还是治疗作用？一项系统综述。
Cureus. 2020 Jul 21;12(7):e9309. doi: 10.7759/cureus.9309.
4
Cannabis use and psychiatric illness in the context of medical marijuana legalization: A clinical perspective.医用大麻合法化背景下的大麻使用与精神疾病：临床视角。
Gen Hosp Psychiatry. 2019 Nov-Dec;61:82-83. doi: 10.1016/j.genhosppsych.2019.08.003. Epub 2019 Aug 15.
5
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.精神障碍的药用大麻：以临床为重点的系统评价。
BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8.
6
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.大麻和大麻素在精神病学中的风险与益处
Am J Psychiatry. 2022 Feb;179(2):98-109. doi: 10.1176/appi.ajp.2021.21030320. Epub 2021 Dec 8.
7
Clinical Approaches to Cannabis: A Narrative Review.临床应用大麻的方法：叙事性综述。
Med Clin North Am. 2022 Jan;106(1):131-152. doi: 10.1016/j.mcna.2021.08.004.
8
Cannabis-based medicines for chronic neuropathic pain in adults.用于成人慢性神经性疼痛的大麻类药物。
Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2.
9
Medical marijuana and the developing role of the pharmacist.医用大麻与药剂师不断演变的角色。
Am J Health Syst Pharm. 2007 May 15;64(10):1037-44. doi: 10.2146/ajhp060471.
10
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.临床使用大麻类药物治疗的数据：文献综述
Ann Pharmacother. 2020 Nov;54(11):1109-1143. doi: 10.1177/1060028020930189. Epub 2020 Jun 2.
引用本文的文献
1
Synthetic CB1 Cannabinoids Promote Tunneling Nanotube Communication, Cellular Migration, and Epithelial-Mesenchymal Transition in Pancreatic PANC-1 and Colorectal SW-620 Cancer Cell Lines.合成CB1大麻素促进胰腺PANC - 1和结肠直肠SW - 620癌细胞系中的隧道纳米管通讯、细胞迁移和上皮-间质转化。
Cells. 2025 Jan 7;14(2):71. doi: 10.3390/cells14020071.
2
Changes in Quantity Measures of Various Forms of Cannabis Consumption among Emerging Adults in Canada in Relation to Policy and Public Health Developments.加拿大成年初期人群中各种形式大麻消费的数量变化与政策和公共卫生发展的关系。
Int J Environ Res Public Health. 2023 Jun 24;20(13):6213. doi: 10.3390/ijerph20136213.
3
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor.在向加拿大消费者销售大麻的网站上提供的健康信息质量很差。
Harm Reduct J. 2022 Dec 12;19(1):138. doi: 10.1186/s12954-022-00691-9.
4
Cannabinoids in rheumatology: Friend, foe or a bystander?大麻素在风湿病学中的应用：朋友、敌人还是旁观者？
Musculoskeletal Care. 2022 Jun;20(2):416-428. doi: 10.1002/msc.1636. Epub 2022 Apr 27.
5
A Quality-of-Life Evaluation Study Assessing Health-Related Quality of Life in Patients Receiving Medicinal Cannabis (the QUEST Initiative): Protocol for a Longitudinal Observational Study.一项评估接受药用大麻患者健康相关生活质量的生活质量评估研究（QUEST计划）：一项纵向观察性研究方案
JMIR Res Protoc. 2021 Nov 24;10(11):e32327. doi: 10.2196/32327.
6
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer.肠道炎症和结直肠癌中大麻素与内源性大麻素系统的变化
Cancers (Basel). 2021 Aug 28;13(17):4353. doi: 10.3390/cancers13174353.
7
Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.内源性大麻素系统针对神经炎性自身免疫性疾病的治疗特性
Molecules. 2021 Jun 3;26(11):3389. doi: 10.3390/molecules26113389.
8
An Unexpected Case of Cannabis-Induced Pancreatitis.一例罕见的大麻所致胰腺炎病例。
Cureus. 2021 Feb 10;13(2):e13253. doi: 10.7759/cureus.13253.
9
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.大麻：一种产生毒素的植物，具有潜在的治疗用途。
Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117.
10
Cannabis for Chronic Pain: Not Ready for Prime Time.大麻用于慢性疼痛：尚不适用于主流治疗。
Am J Public Health. 2019 Jan;109(1):50-51. doi: 10.2105/AJPH.2018.304593.
本文引用的文献
1
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States.美国全国范围内高中高年级学生样本中大麻使用情况及其相关因素。
Am J Drug Alcohol Abuse. 2015 May;41(3):197-205. doi: 10.3109/00952990.2015.1011745. Epub 2015 Apr 10.
2
Cannabis: the never-ending, nefarious nepenthe of the 21st century: what should the clinician know?大麻：21世纪永不停歇的邪恶忘忧药：临床医生应该了解什么？
Dis Mon. 2015 Apr;61(4):118-75. doi: 10.1016/j.disamonth.2015.01.004.
3
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.医用大麻：科学综述及其对发育行为儿科学实践的影响
J Dev Behav Pediatr. 2015 Feb-Mar;36(2):115-23. doi: 10.1097/DBP.0000000000000129.
4
Medical marijuana in neurology.神经病学中的医用大麻。
Expert Rev Neurother. 2014 Dec;14(12):1453-65. doi: 10.1586/14737175.2014.985209.
5
Medical cannabis: US researchers battle for access to the plant.医用大麻：美国研究人员为获取该植物而斗争。
BMJ. 2014 Nov 21;349:g6997. doi: 10.1136/bmj.g6997.
6
Cannabis use and mania symptoms: a systematic review and meta-analysis.大麻使用与躁狂症状：一项系统评价与荟萃分析。
J Affect Disord. 2015 Jan 15;171:39-47. doi: 10.1016/j.jad.2014.09.016. Epub 2014 Sep 23.
7
Medical marijuana for digestive disorders: high time to prescribe?医用大麻治疗消化系统疾病：是时候开处方了？
Am J Gastroenterol. 2015 Feb;110(2):208-14. doi: 10.1038/ajg.2014.245. Epub 2014 Sep 9.
8
A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies.普通人群中焦虑症与大麻使用或大麻使用障碍之间的正相关——31项研究的荟萃分析
BMC Psychiatry. 2014 May 10;14:136. doi: 10.1186/1471-244X-14-136.
9
Association between cannabis use and schizotypal dimensions--a meta-analysis of cross-sectional studies.大麻使用与精神分裂型维度的关联——横断面研究的荟萃分析。
Psychiatry Res. 2014 Sep 30;219(1):58-66. doi: 10.1016/j.psychres.2014.05.008. Epub 2014 May 13.
10
Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know.大麻吸入对心血管、脑血管和外周血管的不良影响：心脏病学家需要了解的内容。
Am J Cardiol. 2014 Jan 1;113(1):187-90. doi: 10.1016/j.amjcard.2013.09.042. Epub 2013 Oct 5.
Zotero 插件